Wolverine Trading’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$47.4K Buy
+27,400
New +$53.7K ﹤0.01% 5426
2025
Q2
Sell
-34,800
Closed -$68.2K 5107
2025
Q1
$68.2K Sell
34,800
-25,100
-42% -$94.2K ﹤0.01% 4334
2024
Q4
$305K Buy
59,900
+33,500
+127% +$166K ﹤0.01% 3988
2024
Q3
$147K Buy
26,400
+8,000
+43% +$52.7K ﹤0.01% 4229
2024
Q2
$88.3K Buy
+18,400
New +$95.8K ﹤0.01% 4101
2023
Q4
Sell
-10,200
Closed -$29.9K 4789
2023
Q3
$29.9K Buy
+10,200
New +$33.7K ﹤0.01% 4266
2021
Q4
Sell
-21,300
Closed -$254K 6289
2021
Q3
$254K Buy
+21,300
New +$244K ﹤0.01% 4968

Other funds holding HUMA

Wolverine Trading's HUMA Position: Q3 2025 in Review

Wolverine Trading opened a new position in Humacyte (HUMA) in Q3 2025: 22,143 shares worth $38.3K. The stake represents ﹤0.01% of the portfolio and ranks #5470 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in HUMA as recently as Q4 2024.

Wolverine Trading first reported a position in HUMA in Q3 2023 and has held it in 7 quarters since. The position peaked at $303K in Q3 2024. 141 funds tracked by Wall St. Rank hold HUMA as of Q3 2025.

  • Wolverine Trading held 22,143 shares of Humacyte worth $38.3K as of Q3 2025.
  • Humacyte was a new Wolverine Trading position in Q3 2025.
  • Humacyte made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5470 holding.
  • Wolverine Trading first reported a position in Humacyte in Q3 2023 and has held it in 7 quarters since.
  • Wolverine Trading's Humacyte position peaked at $303K in Q3 2024.
  • 141 funds tracked by Wall St. Rank held Humacyte as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.